How long should I refrain from sexual activity after treatment for gonorrhea, chlamydia, or trichomoniasis (trich)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Sexual Abstinence After Treatment for STIs

Patients should abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen for gonorrhea, chlamydia, or trichomoniasis to prevent transmission and reinfection. 1

General Abstinence Guidelines

  • Patients treated for chlamydia should abstain from sexual intercourse for 7 days after single-dose azithromycin therapy or until completion of the full 7-day doxycycline regimen 1
  • For gonorrhea treatment, patients should abstain from sexual activity for 7 days after receiving treatment, provided their symptoms have resolved 1
  • Patients treated for trichomoniasis should follow the same abstinence guidelines of 7 days after single-dose therapy or until completion of a multi-day regimen 1
  • Sexual abstinence should continue until all sex partners have been treated to minimize the risk of reinfection 1, 2

Rationale for Abstinence Period

  • The 7-day abstinence period allows time for the antibiotics to effectively clear the infection 1
  • Even with condom use during treatment, there is still risk of transmission or reinfection as condoms may not provide complete protection during acute bacterial STI treatment 3
  • Studies show that sexual activity between treatment and test of cure is common (37% of patients in one study), with 88% reporting inconsistent condom use 4
  • Sexual contact before completing treatment increases the risk of treatment failure and ongoing transmission 3, 4

Partner Management

  • All sex partners from the previous 60 days should be referred for evaluation, testing, and treatment 1
  • Partners should receive the same treatment as the index patient to prevent reinfection 5
  • If the most recent sexual contact was more than 60 days before symptom onset or diagnosis, that partner should still be evaluated and treated 1
  • Expedited partner treatment is an alternative approach when partners are unlikely to seek medical care 1

Follow-Up Recommendations

  • Test-of-cure is NOT routinely recommended for non-pregnant patients treated with recommended regimens for chlamydia or gonorrhea 1, 2
  • Test-of-cure IS recommended for:
    • All pregnant women (3-4 weeks after treatment completion) 2
    • Cases of pharyngeal gonorrhea 6
    • Rectal chlamydia treated with azithromycin 6
  • All patients treated for chlamydia, gonorrhea, or trichomoniasis should be retested approximately 3 months after treatment due to high rates of reinfection 2, 6
  • Diagnostic testing performed less than 3 weeks after treatment may yield false results due to persistent dead organisms 2

Special Considerations

  • For patients with persistent symptoms after treatment, evaluation for reinfection, treatment compliance issues, or other causes should be conducted 5
  • Pregnant patients require special attention with test-of-cure 3-4 weeks after treatment completion 2
  • HIV-positive patients should receive the same treatment and abstinence recommendations as HIV-negative patients 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Chlamydia Retesting Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Ureaplasma STD in Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.